Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma helps protect and improve ovarian function in rats treated with cyclophosphamide.

CD146 + mesenchymal stem cells are more effective for treating premature ovarian failure.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Satoyoshi syndrome can occur without causing premature ovarian failure.

Transvaginal hydrolaparoscopy is effective for increasing ovulation and pregnancy rates in women with PCOS who didn't respond to clomiphene.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Menopause is a clear hormonal transition in women, while men experience a gradual testosterone decline, with some needing lifestyle changes and targeted therapy.

Treating ovarian-related inflammation may help hair regrowth in women with alopecia areata.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Delayed puberty often runs in families, can affect growth, and may need hormone treatment.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Ovulation disorders are a major cause of infertility and menstrual problems in women.

Society's pressure to have children later in life favors genes that increase the risk of early baldness in male offspring.

Human hair follicle stem cells improve ovarian function in mice with damaged ovaries.

The treatment successfully lowered testosterone levels and reduced symptoms.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Shock can be an early sign of Autoimmune Polyendocrine Syndrome Type II.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

Three to five ovarian punctures are best for improving fertility in women with PCOS without harming the ovaries.

PCOS-related infertility is managed with lifestyle changes and medications.